CDC and Pfizer at Odds Over Need for COVID-19 Booster Shots

Priya Nori, M.D., discusses the disagreement between Pfizer and the Centers for Disease Control about COVID-19 booster shots, and says a more important issue is vaccine equity and the need to provide initial shots for healthcare workers in low- and middle-income countries. Dr. Nori is associate professor of medicine and of orthopaedic surgery at Einstein and Montefiore.


Ready for the Next Pandemic? (Spoiler Alert: It's Coming)

Priya Nori, M.D., talks about the re-emergence of multi-drug resistant bacteria and fungi in the wake of the COVID-19 pandemic and the important role infectious disease physicians can play in preventing outbreaks and ensuring patient safety. Dr. Nori is associate professor of medicine and of orthopaedics at Einstein and medical director of the antimicrobial stewardship program at Montefiore.


The FDA Revokes its Emergency Use Authorization for Hydroxychloroquine

Priya Nori, M.D., explains that the FDA's decision to revoke its Emergency Use Authorization for hydroxychloroquine to treat COVID-19 will have little impact on clinicians, many of whom had already shied away from using the antimalarial drug. Dr. Nori is assistant professor of medicine at Einstein and medical director of the antibiotic stewardship program at Montefiore Health System.


Antibiotic Treatment for COVID-19 Complications Could Fuel Resistant Bacteria

Priya Nori, M.D. comments on the use of antibiotics in patients with COVID-19, which could help stem secondary bacterial infections. Dr. Nori is assistant professor of medicine at Einstein and medical director of the antibiotic stewardship program at Montefiore Health System.